Evidence map›Paper›PMID 20838451›Full record

ReviewDeutsches Arzteblatt international2010

The diagnosis and treatment of acute pulmonary embolism.

Alexander Schellhaass, Andreas Walther, Stavros Konstantinides, Bernd W Böttiger

Abstract readReview
In one paragraph

Review in Deutsches Arzteblatt international, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Heart rate in pulmonary embolism.Internal and emergency medicine · 2015
    Article
  10. Article
  11. Article
  12. D-dimer testing for safe exclusion and risk stratification in patients with acute pulmonary embolism in primary care.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2015
    Article
  13. Review
  14. Cardiac troponin I for predicting right ventricular dysfunction and intermediate risk in patients with normotensive pulmonary embolism.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2015
    Article
  15. Review
  16. [Point-of-care testing in preclinical emergency medicine].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2014
    Review
  17. Article
  18. Imaging of acute pulmonary embolism.Emergency radiology · 2013
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Alexander SchellhaassKlinik für Anästhesiologie, Universitätsklinikum Heidelberg, Germany.
Andreas Walther
Stavros Konstantinides
Bernd W Böttiger

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPulmonary embolism (PE) is a cardiovascular emergency with high morbidity and mortality.

methodsReview of relevant literature retrieved by a selective Medline search, including current guidelines.

resultsHemodynamically unstable patients are considered to have high-risk PE, whereas hemodynamically stable patients are considered to have non-high-risk PE. After classification into one of these two risk groups, patients undergo further diagnostic evaluation for PE according to the appropriate risk-adapted algorithm. Patients who are in cardiogenic shock or have persistent arterial hypotension (high-risk PE) should undergo multidetector computed tomography (MDCT) or echocardiography at once, so that a PE, if present, can be treated immediately by thrombolysis. For hemodynamically stable patients with non-high-risk PE the proper diagnostic strategy is determined by the clinical probability of PE, which can be calculated with the aid of validated scoring systems and is based on both MDCT and D-dimer levels. For further risk stratification in hemodynamically stable patients, tests are performed to detect right ventricular dysfunction or myocardial injury, either of which indicates intermediate-risk PE. In addition to specific therapy, patients with high-risk PE, patients at high risk for hemorrhage and these with severe renal insufficiency should be anticoagulated with unfractionated heparin. All other patients should be treated with low-molecular-weight heparin or fondaparinux. Thereafter, long-term oral anticoagulation with vitamin K antagonists is recommended.

conclusionModern algorithms have considerably simplified the diagnosis and treatment of acute PE. It would be desirable for these algorithms to be rapidly implemented in routine practice, because speedy diagnosis and immediate treatment can lower the morbidity and mortality associated with PE.

Indexed as

Acute DiseaseAnticoagulantsEchocardiographyHumansPulmonary EmbolismTomography, X-Ray ComputedAnticoagulants

Identifiers

PMID20838451
PMCPMC2936787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.